scPharmaceuticals's market cap is currently $303.29M. The company's EPS TTM is $-0.34; its P/E ratio is ―; scPharmaceuticals is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is $-0.23. See an overview of income statement, balance sheet, and cash flow financials.
